The latest lymphoma news
Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence…
Statement from the US Leukemia & Lymphoma Society As the nation’s largest organisation serving the…
A new set of guidelines has been developed to assist with the diagnosis and expert…
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and — due to…
This content is password-protected. To view it, please enter the password below. Password:
A treatment that rallies the immune system to destroy cancer raised the survival rate for…
During Blood Cancer Awareness Month Blood Cancer UK releases its comprehensive Action Plan “Taking blood…
Patient outcomes of an international clinical trial for Advanced-stage Hodgkin lymphoma, published recently in The…
Every year, around 100 people are affected by mantle cell lymphoma. A study at Uppsala…
On June 26, 2024, the Food and Drug Administration granted accelerated approval to epcoritamab-bysp, a…